- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 265/24 - 1,3-OxazinesHydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in positions 2 and 4
Patent holdings for IPC class C07D 265/24
Total number of patents in this class: 7
10-year publication summary
|
0
|
1
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Cortex Pharmaceuticals, Inc. | 7 |
1 |
| Fibrotech Therapeutics PTY LTD | 6 |
1 |
| Institute of Materia Medica, Chinese Academy of Medical Sciences | 186 |
1 |
| Institute of Medicinal Molecular Design, Inc. | 6 |
1 |
| Karus Therapeutics Limited | 27 |
1 |
| Shionogi & Co., Ltd. | 880 |
1 |
| Symed Labs Limited | 50 |
1 |
| Other owners | 0 |